کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2798177 1155681 2008 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی علوم غدد
پیش نمایش صفحه اول مقاله
The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients
چکیده انگلیسی

The aim of the study was to evaluate the effect of metformin on markers of endothelial function, vascular inflammation and factors of thrombosis in obese type 2 diabetic patients. Twenty-four type 2 diabetic patients (15 female, 9 male) previously under medical nutrition treatment (MNT) + regular exercise programme (REP) without chronic micro or macrovascular complications with the mean age of 50.5 ± 1.5 years, diabetes duration of 17.9 ± 6.3 months and body mass index (BMI) of 31.7 ± 0.8 kg/m2 were enrolled in the study. In the first 4 weeks, all the patients continued MNT + REP. In the following 12 weeks, metformin (mean daily dosage of 1381 ± 85 mg) was added. After the first period with MNT + REP, BMI, waist circumference, fat percentage, blood pressure and HDL cholesterol decreased significantly. After metformin addition, there was a significant decrement in BMI, waist circumference, fat percentage, fasting and postprandial plasma glucose, hemoglobin A1C, plasminogen activator inhibitor-1 (PAI-1), vascular endothelial growth factor (VEGF) and increment in β cell reserve values of the patients. Our results indicated that, metformin addition had beneficial effect on VEGF and PAI-1 levels in obese type 2 diabetic patients under MNT + REP, independent from its’ favourable effects on BMI and glycemic control.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Diabetes Research and Clinical Practice - Volume 81, Issue 1, July 2008, Pages 56–60
نویسندگان
, , , , , , , , , ,